Evidence for an A2 adenosine receptor in guinea pig lung
D. Ukena, C. Schirren, K. Klotz, and U. Schwabe. Naunyn Schmiedebergs Arch Pharmacol, 331 (1):
89-95(October 1985)Ukena, D Schirren, C G Klotz, K N Schwabe, U In Vitro Germany, west
Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs
Arch Pharmacol. 1985 Oct;331(1):89-95..
Abstract
Adenosine receptors in guinea pig lung were characterized by measurement
of cyclic AMP formation and radioligand binding. 5'-N-Ethylcarboxamidoadenosine
(NECA) increased cyclic AMP levels in lung slices about 4-fold over
basal values with an EC50 of 0.32 mumol/l. N6-R-(-)-Phenylisopropyladenosine
(R-PIA) was 5-fold less potent than NECA. 5'-N-Methylcarboxamidoadenosine
(MECA) and 2-chloroadenosine had EC50-values of 0.29 and 2.6 mumol/l,
whereas adenosine and inosine had no effect. The adenosine receptors
in guinea pig lung can therefore be classified as A2 receptors. Several
xanthine derivatives antagonized the NECA-induced increase in cyclic
AMP levels. 1,3-Diethyl-8-phenylxanthine (DPX; Ki 0.14 mumol/l) was
the most potent analogue, followed by 8-phenyltheophylline (Ki 0.55
mumol/l), 3-isobutyl-1-methylxanthine (IBMX; Ki 2.9 mumol/l) and
theophylline (Ki 8.1 mumol/l). In contrast, enprofylline (1 mmol/l)
enhanced basal and NECA-stimulated cyclic AMP formation. In addition,
we attempted to characterize these receptors in binding studies with
3H NECA. The KD for 3HNECA was 0.25 mumol/l and the maximal number
of binding sites was 12 pmol/mg protein. In competition experiments
MECA (Ki 0.14 mumol/l) was the most potent inhibitor of 3HNECA
binding, followed by NECA (Ki 0.19 mumol/l) and 2-chloroadenosine
(Ki 1.4 mumol/l). These results correlate well with the EC50-values
for cyclic AMP formation in lung slices. However, the Ki-values of
R-PIA and theophylline were 240 and 270 mumol/l, and DPX and 8-phenyltheophylline
did not compete for 3H NECA binding sites. Therefore, a complete
characterization of A2 adenosine receptors by 3HNECA binding was
not achieved.(ABSTRACT TRUNCATED AT 250 WORDS)
Ukena, D Schirren, C G Klotz, K N Schwabe, U In Vitro Germany, west
Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs
Arch Pharmacol. 1985 Oct;331(1):89-95.
%0 Journal Article
%1 Ukena1985
%A Ukena, D.
%A Schirren, C. G.
%A Klotz, K. N.
%A Schwabe, U.
%D 1985
%J Naunyn Schmiedebergs Arch Pharmacol
%K & AMP/biosynthesis Adenosine-5'-(N-ethylcarboxamide) Adenosine/analogs Animals Cell Cyclic Factors Guinea Ligands Lung/*metabolism Membranes/metabolism Pigs Purinergic Pyrrolidinones/pharmacology Rolipram Surface/*metabolism Theophylline/pharmacology Time derivatives/pharmacology Receptor
%N 1
%P 89-95
%T Evidence for an A2 adenosine receptor in guinea pig lung
%U http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2999618
%V 331
%X Adenosine receptors in guinea pig lung were characterized by measurement
of cyclic AMP formation and radioligand binding. 5'-N-Ethylcarboxamidoadenosine
(NECA) increased cyclic AMP levels in lung slices about 4-fold over
basal values with an EC50 of 0.32 mumol/l. N6-R-(-)-Phenylisopropyladenosine
(R-PIA) was 5-fold less potent than NECA. 5'-N-Methylcarboxamidoadenosine
(MECA) and 2-chloroadenosine had EC50-values of 0.29 and 2.6 mumol/l,
whereas adenosine and inosine had no effect. The adenosine receptors
in guinea pig lung can therefore be classified as A2 receptors. Several
xanthine derivatives antagonized the NECA-induced increase in cyclic
AMP levels. 1,3-Diethyl-8-phenylxanthine (DPX; Ki 0.14 mumol/l) was
the most potent analogue, followed by 8-phenyltheophylline (Ki 0.55
mumol/l), 3-isobutyl-1-methylxanthine (IBMX; Ki 2.9 mumol/l) and
theophylline (Ki 8.1 mumol/l). In contrast, enprofylline (1 mmol/l)
enhanced basal and NECA-stimulated cyclic AMP formation. In addition,
we attempted to characterize these receptors in binding studies with
3H NECA. The KD for 3HNECA was 0.25 mumol/l and the maximal number
of binding sites was 12 pmol/mg protein. In competition experiments
MECA (Ki 0.14 mumol/l) was the most potent inhibitor of 3HNECA
binding, followed by NECA (Ki 0.19 mumol/l) and 2-chloroadenosine
(Ki 1.4 mumol/l). These results correlate well with the EC50-values
for cyclic AMP formation in lung slices. However, the Ki-values of
R-PIA and theophylline were 240 and 270 mumol/l, and DPX and 8-phenyltheophylline
did not compete for 3H NECA binding sites. Therefore, a complete
characterization of A2 adenosine receptors by 3HNECA binding was
not achieved.(ABSTRACT TRUNCATED AT 250 WORDS)
@article{Ukena1985,
abstract = {Adenosine receptors in guinea pig lung were characterized by measurement
of cyclic AMP formation and radioligand binding. 5'-N-Ethylcarboxamidoadenosine
(NECA) increased cyclic AMP levels in lung slices about 4-fold over
basal values with an EC50 of 0.32 mumol/l. N6-R-(-)-Phenylisopropyladenosine
(R-PIA) was 5-fold less potent than NECA. 5'-N-Methylcarboxamidoadenosine
(MECA) and 2-chloroadenosine had EC50-values of 0.29 and 2.6 mumol/l,
whereas adenosine and inosine had no effect. The adenosine receptors
in guinea pig lung can therefore be classified as A2 receptors. Several
xanthine derivatives antagonized the NECA-induced increase in cyclic
AMP levels. 1,3-Diethyl-8-phenylxanthine (DPX; Ki 0.14 mumol/l) was
the most potent analogue, followed by 8-phenyltheophylline (Ki 0.55
mumol/l), 3-isobutyl-1-methylxanthine (IBMX; Ki 2.9 mumol/l) and
theophylline (Ki 8.1 mumol/l). In contrast, enprofylline (1 mmol/l)
enhanced basal and NECA-stimulated cyclic AMP formation. In addition,
we attempted to characterize these receptors in binding studies with
[3H] NECA. The KD for [3H]NECA was 0.25 mumol/l and the maximal number
of binding sites was 12 pmol/mg protein. In competition experiments
MECA (Ki 0.14 mumol/l) was the most potent inhibitor of [3H]NECA
binding, followed by NECA (Ki 0.19 mumol/l) and 2-chloroadenosine
(Ki 1.4 mumol/l). These results correlate well with the EC50-values
for cyclic AMP formation in lung slices. However, the Ki-values of
R-PIA and theophylline were 240 and 270 mumol/l, and DPX and 8-phenyltheophylline
did not compete for [3H] NECA binding sites. Therefore, a complete
characterization of A2 adenosine receptors by [3H]NECA binding was
not achieved.(ABSTRACT TRUNCATED AT 250 WORDS)},
added-at = {2010-12-14T18:12:02.000+0100},
author = {Ukena, D. and Schirren, C. G. and Klotz, K. N. and Schwabe, U.},
biburl = {https://www.bibsonomy.org/bibtex/2ed650e4c47ca8294a3f2681fd264e9cc/pharmawuerz},
endnotereftype = {Journal Article},
interhash = {f8739afa5dcb76a80c95bef686691f8c},
intrahash = {ed650e4c47ca8294a3f2681fd264e9cc},
issn = {0028-1298 (Print) 0028-1298 (Linking)},
journal = {Naunyn Schmiedebergs Arch Pharmacol},
keywords = {& AMP/biosynthesis Adenosine-5'-(N-ethylcarboxamide) Adenosine/analogs Animals Cell Cyclic Factors Guinea Ligands Lung/*metabolism Membranes/metabolism Pigs Purinergic Pyrrolidinones/pharmacology Rolipram Surface/*metabolism Theophylline/pharmacology Time derivatives/pharmacology Receptor},
month = Oct,
note = {Ukena, D Schirren, C G Klotz, K N Schwabe, U In Vitro Germany, west
Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs
Arch Pharmacol. 1985 Oct;331(1):89-95.},
number = 1,
pages = {89-95},
shorttitle = {Evidence for an A2 adenosine receptor in guinea pig lung},
timestamp = {2010-12-14T18:20:09.000+0100},
title = {Evidence for an A2 adenosine receptor in guinea pig lung},
url = {http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2999618},
volume = 331,
year = 1985
}